| Literature DB >> 35791365 |
Anna Huta-Osiecka1, Krystian Wochna2, Rafał Stemplewski3, Katarzyna Marciniak3, Tomasz Podgórski4, Zbigniew Kasprzak1, Piotr Leszczyński5, Alicja Nowak1.
Abstract
Background: Regular and individualised physical activities have been shown to prevent adverse changes associated with the aging process. The main purpose of this study was to evaluate changes in carbohydrate and lipid metabolism and white blood cell (WBC) subpopulations in postmenopausal women participating in Nordic walking (NW) training and to compare the use of poles with an integrated resistance shock absorber (RSA) with the use of classic poles. Materials &Entities:
Keywords: Insulin sensitivity; Lipid profile; Nordic walking; Physical activity; Postmenopausal women; Vitamin D
Year: 2022 PMID: 35791365 PMCID: PMC9250761 DOI: 10.7717/peerj.13643
Source DB: PubMed Journal: PeerJ ISSN: 2167-8359 Impact factor: 3.061
Somatic characteristics, biochemical indices and WBC and its specific subpopulations count in two study measurements (before and after training programme) for the entire group of women (n = 23).
| Parameters | Assessment at baseline (term I) | Assessment at the end (term II) |
|---|---|---|
| Body mass (kg) | 68.09 ± 9.60 | 68.70 ± 9.59 |
| 67.2 (62.4–74.8) | 66.6 (62.8–76.2) | |
| BMI (kg/m2) | 26.22 ± 3.38 | 26.47 ± 3.31 |
| 25.5 (23.3–28.7) | 25.8 (23.6–28.9) | |
| Fat mass (kg) | 27.11 ± 6.19 | 26.59 ± 6.11 |
| 26.1 (22.7–31.0) | 25.9 (21.8–30.6) | |
| Fat mass (%) | 40.62 ± 4.63 | 39.98 ± 4.41 |
| 40.3 (37.0–43.7) | 40.8 (36.1–43.2) | |
| 25(OH)D (ng/ml) | 27.01 ± 11.27 | 27.28 ± 10.82 |
| 25.9 (16.1–32.5) | 27.3 (17.8–37.0) | |
| Glucose (mmol/l) | 5.21 ± 0.55 | 5.28 ± 0.55 |
| 5.2 (4.8–5.6) | 5.2 (4.8–5.7) | |
| Insulin (µIU/ml) | 15.28 ± 6.51 | 12.13 ± 6.30 |
| 16.4 (9.5–21.3) | 10.2 (7.7–17.1) | |
| HOMA-IR | 3.56 ± 1.62 | 2.90 ± 1.63 |
| 3.6 (2.2–5.0) | 2.5 (1.5–4.3) | |
| TC (mg/dl) | 209.78 ± 36.51 | 195.70 ± 41.76 |
| 204 (189–240) | 182 (167–223) | |
| TG (mg/dl) | 101.0 ± 59.77 | 91.26 ± 48.43 |
| 87 (64–121) | 81 (59–108) | |
| HDL-C (mg/dl) | 63.71 ± 12.32 | 62.67 ± 11.39 |
| 64.0 (56.8–71.9) | 63.3 (57–70) | |
| LDL-C (mg/dl) | 139.27 ± 39.76 | 138.87 ± 43.98 |
| 128.8 (107.5–165.1) | 130.3 (103.9–178.4) | |
| WBC (109/l) | 6.35 ± 1.37 | 5.42 ± 1.26 |
| 6.3 (4.9–7.2) | 5.3 (4.6–6.0) | |
| LYM (109/l) | 2.1 ± 0.56 | 1.87 ± 0.40 |
| 2.0 (1.7–2.4) | 1.8 (1.5–2.3) | |
| MON (109/l) | 0.45 ± 0.12 | 0.27 ± 0.07 |
| 0.4 (0.4–0.5) | 0.3 (0.2–0.3) | |
| GRA (109/l) | 3.81 ± 1.12 | 3.27 ± 0.99 |
| 3.7 (2.8–4.7) | 3.1 (2.8–3.5) |
Notes.
Results are expressed as mean (SD); median (interquartile range).
An asterisk (*) indicate p < 0.054, two asterisks (**) indicate p < 0.01; significant differences between the first and second terms of the study.
body mass index
25-hydroxyvitamin D
homeostatic model assessment of insulin resistance index
total cholesterol
triglycerides
high density lipoprotein cholesterol
low density lipoprotein cholesterol
white blood cells
lymphocytes
monocytes
granulocytes
Somatic characteristics, biochemical indices and WBC and its specific subpopulations counts in the two study terms for two groups of women divided by the type of poles (RSA, n = 8 and NW, n = 15).
| Parameters | Groups | Assessment at baseline (term I) | Assessment at the end (term II) |
|---|---|---|---|
| Body mass (kg) | RSA | 69.70 ± 8.33 | 69.83 ± 8.47 |
| NW | 67.23 ± 10.38 | 68.09 ± 10.37 | |
| BMI (kg/m2) | RSA | 26.88 ± 3.46 | 26.96 ± 3.38 |
| NW | 25.87 ± 3.41 | 26.21 ± 3.36 | |
| Fat mass (kg) | RSA | 27.31 ± 6.30 | 26.30 ± 6.07 |
| NW | 27.00 ± 6.35 | 26.75 ± 6.34 | |
| Fat mass (%) | RSA | 39.71 ± 5.08 | 38.69 ± 5.13 |
| NW | 41.10 ± 4.47 | 40.67 ± 4.00 | |
| 25(OH)D (ng/ml) | RSA | 31.69 ± 14.32 | 32.24 ± 11.62 |
| NW | 24.51 ± 8.83 | 24.63 ± 9.74 | |
| Glucose (mmol/l) | RSA | 5.12 ± 0.76 | 5.11 ± 0.68 |
| NW | 5.25 ± 0.42 | 5.36 ± 0.46 | |
| Insulin (µIU/ml) | RSA | 16.07 ± 5.04 | 11.66 ± 5.67 |
| NW | 14.86 ± 7.30 | 12.38 ± 6.79 | |
| HOMA-IR | RSA | 3.68 ± 1.32 | 2.75 ± 1.65 |
| NW | 3.50 ± 1.81 | 2.97 ± 1.68 | |
| TC (mg/dl) | RSA | 220.38 ± 35.62 | 197.38 ± 38.76 |
| NW | 204.13 ± 36.91 | 194.80 ± 44.57 | |
| TG (mg/dl) | RSA | 100.63 ± 33.38 | 84.25 ± 28.32 |
| NW | 101.20 ± 71.11 | 95.00 ± 56.93 | |
| HDL-C (mg/dl) | RSA | 66.71 ± 15.01 | 61.86 ± 11.25 |
| NW | 62.11 ± 10.85 | 63.11 ± 11.83 | |
| LDL-C (mg/dl) | RSA | 140.26 ± 45.93 | 141.38 ± 48.60 |
| NW | 138.74 ± 37.81 | 137.54 ± 43.05 | |
| WBC (109/l) | RSA | 5.95 ± 1.24 | 5.50 ± 1.25 |
| NW | 6.57 ± 1.44 | 5.37 ± 1.31 | |
| LYM (109/l) | RSA | 2.17 ± 0.29 | 1.98 ± 0.40 |
| NW | 2.06 ± 0.67 | 1.81 ± 0.39 | |
| MON (109/l) | RSA | 0.43 ± 0.13 | 0.25 ± 0.05 |
| NW | 0.47 ± 0.12 | 0.29 ± 0.07 | |
| GRA (109/l) | RSA | 3.35 ± 1.07 | 3.25 ± 1.08 |
| NW | 4.06 ± 1.10 | 3.28 ± 0.98 |
Notes.
Group RSA: poles with an integrated resistance shock absorber
Group NW: classic poles Results are expressed as mean ± SD
An asterisk (*) indicate p < 0.05, two asterisks (**) indicate p < 0.01; significant differences between the first and second terms of the study.
body mass index
25-hydroxyvitamin D
homeostatic model assessment of insulin resistance index
total cholesterol
triglycerides
high density lipoprotein cholesterol
low density lipoprotein cholesterol
white blood cells
lymphocytes
monocytes
granulocytes